OPTIMYXIN PLUS 1.75 MG
NEOMYCIN (NEOMYCIN SULFATE) : 1.75 MG POLYMYXIN B (POLYMYXIN B SULFATE) : 10000 UNIT GRAMICIDIN : 0.025 MG · DIN 00807435 · EURO-PHARM INTERNATIONAL CANADA INC
Health Canada status: CANCELLED POST MARKET
What is OPTIMYXIN PLUS?
OPTIMYXIN PLUS 1.75 MG contains NEOMYCIN (NEOMYCIN SULFATE) : 1.75 MG POLYMYXIN B (POLYMYXIN B SULFATE) : 10000 UNIT GRAMICIDIN : 0.025 MG. It is listed in the Health Canada Drug Product Database under DIN 00807435, held by EURO-PHARM INTERNATIONAL CANADA INC, supplied as SOLUTION for OTIC ; OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 21-Mar-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00807435 |
|---|---|
| Brand name | OPTIMYXIN PLUS |
| Generic / active ingredient | NEOMYCIN (NEOMYCIN SULFATE) : 1.75 MG POLYMYXIN B (POLYMYXIN B SULFATE) : 10000 UNIT GRAMICIDIN : 0.025 MG |
| Manufacturer | EURO-PHARM INTERNATIONAL CANADA INC |
| Strength | 1.75 MG |
| Dosage form | SOLUTION |
| Route of administration | OTIC ; OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S03AA30 ANTIINFECTIVES, COMBINATIONS |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 21-Mar-2022 |
| Original market date | 1989-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S03AA30 ANTIINFECTIVES, COMBINATIONS. 3 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| OPTIMYXIN | 10000 UNIT | DROPS | EURO-PHARM INTERNATIONAL CANADA INC | MARKETED | DIN 00701785 |
| POLYSPORIN EYE AND EAR DROPS STERILE | 10000 UNIT | DROPS | JOHNSON & JOHNSON INC | MARKETED | DIN 02239156 |
| SOOTHE ANTIBIOTIC DROPS | 10000 UNIT | DROPS | BAUSCH & LOMB INC | MARKETED | DIN 02552418 |
| ANTIBIOTIC DROPS | 0.025 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02457512 |
| ANTIBIOTIC EYE DROPS | 0.025 MG | DROPS | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02458713 |
| NEOSPORIN EYE-EAR SOLUTION | 10000 UNIT | SOLUTION | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 00694371 |
| POLYCIDIN EYE, EAR DROPS | 0.025 MG | LIQUID | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | DIN 02229903 |
| POLYSPORIN EYE AND EAR DROPS STERILE | 10000 UNIT | DROPS | GLAXO WELLCOME INC. | CANCELLED POST MARKET | DIN 00035343 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.